CIK 0001728328 · <br>Emerging growth company
InMed Pharmaceuticals Inc.
Sign in to watch- Tickers
- INM MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 669-7207
- Business address
- C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
Securities
- INM Common stock Nasdaq
- MTRI Common Stock Nasdaq
- Open-market buys, last 90 days
- $238,371
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$238,371. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-23 | HULL ANDREW Director | Grant or award · Employee Stock Option (Right to Buy) | +7,100 | 8,584 | ||
| 2023-12-05 | WOUDENBERG MICHAEL Chief Operating Officer | Other disposition · Employee Stock Option (Expiration) | −848 | 10,494 | ||
| 2023-08-31 | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | Other disposition · Employee Stock Option (Expiration) | −327 | 7,854 | ||
| 2023-05-16 | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | Other disposition · Employee Stock Option (Expiration) | −152 | 8,181 | ||
| 2023-05-16 | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | Other disposition · Employee Stock Option (Expiration) | −485 | 7,606 | ||
| 2023-05-16 | ADAMS ERIC A President & CEO | Other disposition · Employee Stock Option (Expiration) | −1,818 | 26,139 | ||
| 2023-03-08 | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | Other disposition · Employee Stock Option (Expiration) | −61 | 8,091 | ||
| 2023-03-08 | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | Other disposition · Employee Stock Option (Expiration) | −545 | 8,333 | ||
| 2023-03-08 | ADAMS ERIC A President & CEO | Other disposition · Employee Stock Option (Expiration) | −545 | 27,957 | ||
| 2022-12-16 | Li Sarah VP Accounting & Controller | Grant or award · Employee Stock Option (Right to Buy) | +3,600 | 4,002 | ||
| 2022-12-16 | Johnson Shane Aaron Sr VP & General Manager | Grant or award · Employee Stock Option (Right to Buy) | +4,200 | 8,000 | ||
| 2022-12-16 | Lemerond Nicole Director | Grant or award · Employee Stock Option (Right to Buy) | +840 | 1,400 | ||
| 2022-12-16 | WOUDENBERG MICHAEL Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +7,500 | 11,342 | ||
| 2022-12-16 | Tegge Jonathan Interim CFO | Grant or award · Employee Stock Option (Right to Buy) | +1,400 | 1,400 | ||
| 2022-12-16 | Grove Janet P Director | Grant or award · Employee Stock Option (Right to Buy) | +840 | 1,400 | ||
| 2022-12-16 | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | Grant or award · Employee Stock Option (Right to Buy) | +4,200 | 8,878 | ||
| 2022-12-16 | ADAMS ERIC A President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +15,000 | 28,502 | ||
| 2022-12-16 | Baldasare Bryan T Director | Grant or award · Employee Stock Option (Right to Buy) | +840 | 1,400 | ||
| 2022-12-16 | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | Grant or award · Employee Stock Option (Right to Buy) | +4,200 | 8,152 | ||
| 2022-12-16 | HULL ANDREW Director | Grant or award · Employee Stock Option (Right to Buy) | +840 | 1,484 |
Page 6 of 8 · 149 trades